Literature DB >> 29301438

Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.

Meng Yue1, Shiquan Li1, Guoqiang Yan1, Chenyao Li1, Zhenhua Kang1.   

Abstract

Paeoniflorin (PF) exhibits tumor suppressive functions in a variety of human cancers. However, the function of PF and molecular mechanism in colorectal cancer are elusive. In the present study, we investigated whether PF could exert its antiproliferative activity, anti-migration, and anti-invasive function in colorectal cancer cells. We found that PF inhibited cell growth and induced apoptosis and blocked cell cycle progression in the G0/G1 phase in colorectal cancer cells. Moreover, we found that PF suppressed cell migration and invasion in colorectal cancer cells. FoxM1 has been reported to play an important oncogenic role in human cancers. We also determine whether PF inhibited the expression of FoxM1, leading to its anti-cancer activity. We found that PF treatment in colorectal cancer cells resulted in down-regulation of FoxM1. The rescue experiments showed that overexpression of FoxM1 abrogated the tumor suppressive function induced by PF treatment. Notably, depletion of FoxM1 promoted the anti-tumor activity of PF in colorectal cancer cells. Therefore, inhibition of FoxM1 could participate in the anti-tumor activity of PF in colorectal cancer cells.

Entities:  

Keywords:  FoxM1; Paeoniflorin; cell cycle; colorectal cancer; invasion; proliferation

Mesh:

Substances:

Year:  2018        PMID: 29301438      PMCID: PMC5884122          DOI: 10.1080/15384101.2017.1407892

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  56 in total

Review 1.  FOXM1, a typical proliferation-associated transcription factor.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2007-12       Impact factor: 3.915

2.  Colorectal cancer statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-03-01       Impact factor: 508.702

Review 3.  FOXM1 in Cancer: Interactions and Vulnerabilities.

Authors:  Andrei L Gartel
Journal:  Cancer Res       Date:  2017-06-05       Impact factor: 12.701

4.  Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling.

Authors:  Nanmu Yang; Hong Cui; Feng Han; Ling Zhang; Tao Huang; Yi Zhou; Jinxue Zhou
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

5.  Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.

Authors:  Jen-Yu Hung; Chih-Jen Yang; Ying-Ming Tsai; Hurng-Wern Huang; Ming-Shyan Huang
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-10-17       Impact factor: 2.557

Review 6.  The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.

Authors:  Inken Wierstra
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 7.  Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.

Authors:  Lijun Li; Dang Wu; Qun Yu; Lingdi Li; Pin Wu
Journal:  Oncotarget       Date:  2017-05-09

8.  A novel FOXM1 isoform, FOXM1D, promotes epithelial-mesenchymal transition and metastasis through ROCKs activation in colorectal cancer.

Authors:  X Zhang; L Zhang; Y Du; H Zheng; P Zhang; Y Sun; Y Wang; J Chen; P Ding; N Wang; C Yang; T Huang; X Yao; Q Qiao; H Gu; G Cai; S Cai; X Zhou; W Hu
Journal:  Oncogene       Date:  2016-07-11       Impact factor: 9.867

9.  Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway.

Authors:  Xiao-hu Nie; Jia Ou-yang; Ying Xing; Dan-yan Li; Xing-yu Dong; Ru-en Liu; Ru-xiang Xu
Journal:  Drug Des Devel Ther       Date:  2015-10-13       Impact factor: 4.162

Review 10.  The roles of FOXM1 in pancreatic stem cells and carcinogenesis.

Authors:  Ming Quan; Peipei Wang; Jiujie Cui; Yong Gao; Keping Xie
Journal:  Mol Cancer       Date:  2013-12-10       Impact factor: 27.401

View more
  8 in total

Review 1.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

2.  Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis.

Authors:  Funda Demirtas Korkmaz; Irem Dogan Turacli; Guldal Esendagli; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

3.  Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.

Authors:  Cheng Chen; Yang Tang; Wen-Dong Qu; Xu Han; Jie-Bin Zuo; Qing-Yong Cai; Gang Xu; Yong-Xiang Song; Xi-Xian Ke
Journal:  BMC Cancer       Date:  2021-05-26       Impact factor: 4.430

4.  New insights into Paeoniaceae used as medicinal plants in China.

Authors:  Xiaoxiao Zhang; Yuhui Zhai; Junhui Yuan; Yonghong Hu
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

5.  Anti-Lung Cancer Targets of Radix Paeoniae Rubra and Biological Molecular Mechanism: Network Pharmacological Analyses and Experimental Validation.

Authors:  Yunfei Ma; Guangda Li; Mingwei Yu; Kexin Cao; Qiwei Li; Xu Sun; Guowang Yang; Xiaomin Wang
Journal:  Onco Targets Ther       Date:  2021-03-16       Impact factor: 4.147

Review 6.  A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics.

Authors:  Yan-Ling Zhang; Yan Ma; You-Qin Zeng; Yan Liu; En-Ping He; Yi-Tong Liu; Feng-Ling Qiao; Rong Yu; Ying-Shuang Wang; Xin-Yu Wu; Ping Leng
Journal:  Ann Transl Med       Date:  2021-11

7.  Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis.

Authors:  Yizhou Yao; Xuchao Wang; Linhua Jiang; Xinyu Shao; Xinguo Zhu; Songbing He
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  Paeoniflorin Enhances Endometrial Receptivity through Leukemia Inhibitory Factor.

Authors:  Hye-Rin Park; Hee-Jung Choi; Bo-Sung Kim; Tae-Wook Chung; Keuk-Jun Kim; Jong-Kil Joo; Dongryeol Ryu; Sung-Jin Bae; Ki-Tae Ha
Journal:  Biomolecules       Date:  2021-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.